Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.
暂无分享,去创建一个
Veniamin Y Sidorov | J. Potter | F. Baudenbacher | B. Knollmann | R. Solaro | V. Sidorov | Franz Baudenbacher | R John Solaro | Björn C Knollmann | Jose Renato Pinto | James D Potter | Tilmann Schober | Fredrick Hilliard | J. Pinto | T. Schober | Fredrick A. Hilliard | R. Solaro | Jose Renato Pinto | James D. Potter | J. R. Pinto
[1] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[2] P. Kirchhof,et al. Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling , 2003, Circulation research.
[3] J. Potter,et al. Expanding the range of free calcium regulation in biological solutions. , 2005, Analytical biochemistry.
[4] R. Mentzer,et al. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. , 1996, The Journal of clinical investigation.
[5] D. Szczesna,et al. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. , 2001, The Journal of biological chemistry.
[6] D. Duncker,et al. Alterations in Myofilament Function Contribute to Left Ventricular Dysfunction in Pigs Early After Myocardial Infarction , 2004, Circulation research.
[7] B B Lerman,et al. Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability. , 1985, The Journal of clinical investigation.
[8] Bruno Taccardi,et al. Epicardial and intramural excitation during ventricular pacing: effect of myocardial structure. , 2008, American journal of physiology. Heart and circulatory physiology.
[9] G. Guzman,et al. F110I and R278C Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy Affect Muscle Contraction in Transgenic Mice and Reconstituted Human Cardiac Fibers* , 2005, Journal of Biological Chemistry.
[10] H. L. Stone,et al. The effects of daily exercise on susceptibility to sudden cardiac death. , 1984, Circulation.
[11] A. Garfinkel,et al. Mechanisms of Discordant Alternans and Induction of Reentry in Simulated Cardiac Tissue , 2000, Circulation.
[12] A. Marian,et al. The molecular genetic basis for hypertrophic cardiomyopathy. , 2001, Journal of molecular and cellular cardiology.
[13] L. Harris,et al. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy , 2007, Heart.
[14] F O Mueller,et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.
[15] J. Potter,et al. Effect of rigor and cycling cross-bridges on the structure of troponin C and on the Ca2+ affinity of the Ca2+-specific regulatory sites in skinned rabbit psoas fibers. , 1987, The Journal of biological chemistry.
[16] S. Ebrahim,et al. Exercise‐based Rehabilitation for Coronary Heart Disease , 2001, The Cochrane database of systematic reviews.
[17] Z. Papp,et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.
[18] P. J. Griffiths,et al. Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.
[19] M. C. Woods,et al. Effects of elevated extracellular potassium on the stimulation mechanism of diastolic cardiac tissue. , 2003, Biophysical journal.
[20] J. Potter,et al. A Direct Regulatory Role for Troponin T and a Dual Role for Troponin C in the Ca2+ Regulation of Muscle Contraction (*) , 1995, The Journal of Biological Chemistry.
[21] M R Franz,et al. Monophasic Action Potential Recordings from Intact Mouse Heart: Validation, Regional Heterogeneity, and Relation to Refractoriness , 2001, Journal of cardiovascular electrophysiology.
[22] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.
[23] George A. Mensah,et al. Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.
[24] H. Watkins,et al. Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.
[25] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[26] J J Heger,et al. Sudden cardiac death. , 1998, Circulation.
[27] J. Tardiff,et al. Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. , 2005, American journal of physiology. Heart and circulatory physiology.
[28] P. Toutouzas,et al. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene. , 2004, The American journal of cardiology.
[29] E. Lakatta,et al. Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. , 1993, Circulation research.
[30] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.
[31] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[32] Joshua I. Goldhaber,et al. Action Potential Duration Restitution and Alternans in Rabbit Ventricular Myocytes: The Key Role of Intracellular Calcium Cycling , 2005, Circulation research.
[33] J. Potter,et al. The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. , 1982, The Journal of biological chemistry.
[34] G. Billman,et al. Effects of endurance exercise training on heart rate variability and susceptibility to sudden cardiac death: protection is not due to enhanced cardiac vagal regulation. , 2006, Journal of applied physiology.
[35] P. Elliott,et al. Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene. , 1999, The New England journal of medicine.
[36] A. Arner,et al. Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle. , 2007, American journal of physiology. Cell physiology.
[37] G. Duker,et al. Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic , 2001, Circulation.
[38] J. Parissis,et al. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. , 2006, The American journal of cardiology.
[39] F. Morady,et al. Effects of high stimulation current on the induction of ventricular tachycardia. , 1985, The American journal of cardiology.
[40] J. Ingwall,et al. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. , 2003, The Journal of clinical investigation.
[41] D. Roden,et al. A genetic framework for improving arrhythmia therapy , 2008, Nature.
[42] I. Efimov,et al. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. , 2007, Heart rhythm.
[43] N. Weissman,et al. Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy* , 2001, The Journal of Biological Chemistry.
[44] P. Elliott,et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.
[45] Erik G. Ellsworth,et al. Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy , 2003, Circulation.
[46] A. Garfinkel,et al. From Pulsus to Pulseless: The Saga of Cardiac Alternans , 2006, Circulation research.
[47] B. Sykes,et al. Structure of the C-domain of Human Cardiac Troponin C in Complex with the Ca2+ Sensitizing Drug EMD 57033* , 2001, The Journal of Biological Chemistry.
[48] B. Wolska,et al. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions , 2001, The Journal of physiology.
[49] G. Boriani,et al. Electrophysiologic Manifestations of Ventricular Tachyarrhythmias Provoking Appropriate Defibrillator Interventions in High‐Risk Patients with Hypertrophic Cardiomyopathy , 2007, Journal of cardiovascular electrophysiology.
[50] R. Moss,et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart , 1999, The Journal of physiology.
[51] D. Szczesna,et al. Abnormal Contractile Function in Transgenic Mice Expressing a Familial Hypertrophic Cardiomyopathy-linked Troponin T (I79N) Mutation* , 2001, The Journal of Biological Chemistry.
[52] K. Sipido,et al. Early Exercise Training Normalizes Myofilament Function and Attenuates Left Ventricular Pump Dysfunction in Mice With a Large Myocardial Infarction , 2007, Circulation research.
[53] P. Elliott,et al. Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy , 2006, Heart.
[54] J. White,et al. Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle. , 1993, Circulation research.